Latest Breaking News On - Head of late phase development - Page 1 : comparemela.com

Blueprint Medicines (BPMC) Appoints John Tsai to its Board

Blueprint Medicines (BPMC) Appoints John Tsai to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kate havilandJohn tsaiBristol myers squibbBlueprint medicines corporationOncology development leaderUniversity of louisville school medicineBristol myers squibb companyHead of late phase developmentDrug developmentHead of worldwide medical affairsGlobal drug developmentPfizer incWashington university in stGlobal medical affairs at amgen incWall streetMedicines corporation

Blueprint Medicines Appoints John Tsai, M D to its Board of Directors

Blueprint Medicines Appoints John Tsai, M D to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKate havilandJohn tsaiBristol myers squibbOncology development leaderUniversity of louisville school medicineBristol myers squibb companyHead of worldwide medical affairsPfizer incGlobal medical affairs at amgen incBlueprint medicines corporationHead of late phase developmentDrug developmentExchange commissionPrnewswire blueprint medicines corporation

Blueprint Medicines Appoints John Tsai, M D to its Board of Directors

/PRNewswire/ Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of John Tsai, M.D., to its board of directors. Dr. Tsai, who was.

United statesUnited kingdomKate havilandJohn tsaiBristol myers squibbOncology development leaderUniversity of louisville school medicineBristol myers squibb companyHead of late phase developmentDrug developmentExchange commissionHead of worldwide medical affairsGlobal drug developmentPfizer incPrnewswire blueprint medicines corporationGlobal medical affairs at amgen inc